Cargando…
Lipoprotein-associated phospholipase A(2) and risk of coronary disease, stroke, and mortality: collaborative analysis of 32 prospective studies
BACKGROUND: Lipoprotein-associated phospholipase A(2) (Lp-PLA(2)), an inflammatory enzyme expressed in atherosclerotic plaques, is a therapeutic target being assessed in trials of vascular disease prevention. We investigated associations of circulating Lp-PLA(2) mass and activity with risk of corona...
Formato: | Texto |
---|---|
Lenguaje: | English |
Publicado: |
Lancet Publishing Group
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2864403/ https://www.ncbi.nlm.nih.gov/pubmed/20435228 http://dx.doi.org/10.1016/S0140-6736(10)60319-4 |
Ejemplares similares
-
Risk of adverse coronavirus disease 2019 outcomes for people living with HIV
por: Mellor, Maya M., et al.
Publicado: (2021) -
Pharmacogenetics-guided dalcetrapib therapy after an acute coronary syndrome:
the dal-GenE trial( )
por: Tardif, Jean Claude, et al.
Publicado: (2022) -
Behavioral responses to risk promote vaccinating high‐contact individuals first
por: Rahmandad, Hazhir
Publicado: (2022) -
Parallel Speciation of Wild Rice Associated with Habitat Shifts
por: Cai, Zhe, et al.
Publicado: (2019) -
Selection in Europeans on Fatty Acid Desaturases Associated with Dietary Changes
por: Buckley, Matthew T., et al.
Publicado: (2017)